[Pubmed] Current Treatment of Myasthenia Gravis
Posté : 25 mars 2022 11:00
J Clin Med. 2022 Mar 14;11(6):1597. doi: 10.3390/jcm11061597.
ABSTRACT
Myasthenia gravis (MG) is the most extensively studied antibody-mediated disease in humans. Substantial progress has been made in the treatment of MG in the last century, resulting in a change of its natural course from a disease with poor prognosis with a high mortality rate in the early 20th century to a treatable condition with a large proportion of patients attaining very good disease control. This review summarizes the current treatment options for MG, including non-immunosuppressive and immunosuppressive treatments, as well as thymectomy and targeted immunomodulatory drugs.
PMID:35329925 | DOI:10.3390/jcm11061597
Source: https://pubmed.ncbi.nlm.nih.gov/3532992 ... 7&v=2.17.6